This company listing is no longer active
Taisho Pharmaceutical Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Taisho Pharmaceutical Holdings has a total shareholder equity of ¥857.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥1,005.5B and ¥148.2B respectively. Taisho Pharmaceutical Holdings's EBIT is ¥18.9B making its interest coverage ratio -4. It has cash and short-term investments of ¥266.4B.
Anahtar bilgiler
0%
Borç/özkaynak oranı
JP¥0
Borç
| Faiz karşılama oranı | -4x |
| Nakit | JP¥266.37b |
| Eşitlik | JP¥857.30b |
| Toplam yükümlülükler | JP¥148.17b |
| Toplam varlıklar | JP¥1.01t |
Son finansal sağlık güncellemeleri
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: TAIP.Y's short term assets (¥416.8B) exceed its short term liabilities (¥80.8B).
Uzun Vadeli Yükümlülükler: TAIP.Y's short term assets (¥416.8B) exceed its long term liabilities (¥67.3B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: TAIP.Y is debt free.
Borcun Azaltılması: TAIP.Y has not had any debt for past 5 years.
Borç Kapsamı: TAIP.Y nin borcu yoktur, bu nedenle işletme nakit akışı tarafından karşılanması gerekmez.
Faiz Kapsamı: TAIP.Y has no debt, therefore coverage of interest payments is not a concern.